Gelonghui reported on December 13 that FOSUN PHARMA (02196.HK) announced that on December 13, 2024, it would spend 2.6635 million Hong Kong dollars to repurchase 0.1855 million shares, with a repurchase price per share ranging from 14.3 to 14.46 Hong Kong dollars.
复星医药(02196.HK)12月13日耗资266.35万港元回购18.55万股
On December 13, FOSUN PHARMA (02196.HK) spent HKD 2.6635 million to repurchase 0.1855 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.